Manufactured at Nouryon’s GMP-certified facility in Finland, Cekol CMC-Na is a water-soluble polymer that gives drugmakers a plant-based alternative to synthetic excipients, dissolving readily in formulations where less-soluble alternatives can be harder to process. It binds tablet ingredients, thickens syrups and keeps active ingredients evenly suspended for consistent dosing, and is also used in tablet coatings, eye drops and gels to control how quickly active ingredients are released.
Nouryon has secured Chinese regulatory clearance to supply Cekol CMC-Na, a plant-based carboxymethyl cellulose excipient, for medicines made and sold in China.
Approved under National Medical Products Administration rules, the water-soluble polymer is produced at Nouryon’s GMP-certified facility in Finland.
The excipient is used in tablets, syrups, coatings, eye drops and gels.
“China sets a high bar for drug ingredients, and this approval makes our product available to drugmakers there,” said Bahar Azimipour, global vice president of Nouryon’s Pharmaceutical business. “This approval builds on our global supply of pharmaceutical-grade CMC that is already trusted by drugmakers around the world and extends that opportunity to serve customers into China.”
Nouryon’s broad pharmaceutical specialty chemicals portfolio – spanning chromatography purification resins, excipients, and oral and wound care ingredients – support the manufacture and delivery of active pharmaceutical ingredients and formulations across the entire drug lifecycle, from early-stage research through commercial manufacturing, meeting international quality standards at every step.
Within Nouryon’s Consumer and Life Sciences segment, pharmaceutical offerings are part of the company’s Life Sciences business unit that sells chemistries to advance modern medicines and improve crop yields.
Note: The headline, insights, and image of this press release may have been refined by the ALCHEMPro staff; the rest of the content remains unchanged.
ALCHEMPro News Desk (JP)
